HOME >> BIOLOGY >> NEWS
Smallpox vaccines

THE claim that Britain's smallpox vaccine is less likely to protect people in the event of a bioterrorist attack than the US version sparked a political row last week. But the US government's top adviser on smallpox has told New Scientist that they are both equally likely to work.

The claim that the British vaccine is inferior was made by Stephen Prior of the Potomac Institute for Policy Studies. He looked at which vaccines were used where, and with what success, during the eradication programmes of the 1960s and 1970s.

Two vaccines were used widely during this time. One was developed by the Lister Institute in Britain, the other by the New York City Board of Health. Last year, as fears grew that terrorists would try a smallpox attack, the US ordered the NYCBH strain from a company called Acambis. This April, Britain ordered the Lister strain from another company, PowderJect.

The British government is already under fire for awarding the contract to PowderJect without putting it out to competitive tender, especially as the head of the company has made contributions to the governing Labour Party. So the media seized on Prior's charges that PowderJect's vaccine may not protect against the smallpox strain most likely to be used by terrorists: India-1967, which was mass-produced by the Soviet Union.

Prior says the Lister strain was used later in the eradication drive, in places where the virus was no longer in circulation, whereas the NYCBH strain was more widely used where smallpox was still endemic, especially in India, where India-1967 was probably circulating. "It would therefore seem logical to have any vaccine-based defence [use] the vaccine strains that exhibited success during the eradication campaign," he concludes.

But DA Henderson of Johns Hopkins University, who led the smallpox eradication drive and is the US's chief smallpox adviser, rejects Prior's claims. He says the Lister strain was used to eliminate the virus
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
7-Aug-2002


Page: 1 2

Related biology news :

1. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
2. Smallpox in Europe selected for genetic mutation that confers resistance to HIV infection
3. Smallpox vaccination grinds to halt
4. CDC Telebriefing: Smallpox educational activities and West Nile Virus update
5. Inadequate vaccines can help breed more vicious malaria strains
6. Researcher issues caution on live virus vaccines
7. Scientists learn how adjuvant makes vaccines effective
8. Thimerosal, found in childhood vaccines, can increase the risk of autism-like damage in mice
9. Botulinum toxin structure offers clues for vaccines/treatments
10. Gates Foundation commits $82.9 million to develop new tuberculosis vaccines
11. A link between thimerosal and the brain: Can vaccines affect central nervous system function?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2020)... ... 2020 , ... Pebble Labs USA Inc. , a biotechnology company developing ... the mission of improving global food security, announced today that they have been selected ... Food- and Ag-Tech ' virtual event, a global initiative to drive innovation in feeding ...
(Date:4/26/2020)... Md. (PRWEB) , ... April 23, 2020 , ... ... sector, specializing in computer miniaturization, backed by FII Tech Growth managed by Fondo ... operating in the biomedical market, for the development of Respira, a new non-invasive ...
(Date:4/22/2020)... ... 21, 2020 , ... Captis Biotechnology, Inc. announced it has ... patent development support for early stage startups. The investment will support Captis’ mission ... and precancerous pancreatic lesions with simple, accurate and practical technology. , “We are ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... May 14, 2020 , ... This new service offers clients a way ... questions answered quickly as the need arises. Lachman’s OnCall SMEs have extensive knowledge of ... rates. , Lachman OnCall™ SMEs are available normal business hours Monday through Friday ...
(Date:5/14/2020)... ... 12, 2020 , ... DuPont Nutrition & Biosciences (N&B) has ... personal care ingredients in Russia and Belarus. Beginning May 1, Interdisp JCS will ... care. , The GENENCARE®OSMS product line contains a range of all-natural, ...
(Date:5/14/2020)... ... May 13, 2020 , ... In collaboration with ... Workflows in the Life Science Lab . The comprehensive information source was created ... purification and liquid handling to contamination control. , The content hub features the ...
(Date:5/9/2020)... ... , ... Worldwide Business with kathy ireland® will be LIVE ... 2020 and Wednesday, May 13, 2020 at 8:00pm ET / PT – prime ... from Techolution and Bravado Pharmaceuticals . , As leaders in ...
Breaking Biology Technology:
Cached News: